Cargando…
Preparation and characterization of novel chitosan–protamine nanoparticles for nucleus-targeted anticancer drug delivery
It is well known that most anticancer drugs commonly show high toxicity to the DNA of tumor cells and exert effects by combining with the DNA or associated enzymes in the nucleus. Most developed drugs are first delivered into the cytoplasm and then transferred to the nucleus through the membrane por...
Autores principales: | Yu, Xiwei, Hou, Jiahui, Shi, Yijie, Su, Chang, Zhao, Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5115688/ https://www.ncbi.nlm.nih.gov/pubmed/27881917 http://dx.doi.org/10.2147/IJN.S117066 |
Ejemplares similares
-
Triphenyl Phosphine-Functionalized Chitosan Nanoparticles Enhanced Antitumor Efficiency Through Targeted Delivery of Doxorubicin to Mitochondria
por: Hou, Jiahui, et al.
Publicado: (2017) -
Preparation of Biocompatible Carboxymethyl Chitosan Nanoparticles for Delivery of Antibiotic Drug
por: Zhao, Liang, et al.
Publicado: (2013) -
Hyaluronic acid-coated chitosan nanoparticles induce ROS-mediated tumor cell apoptosis and enhance antitumor efficiency by targeted drug delivery via CD44
por: Wang, Tao, et al.
Publicado: (2017) -
Intracellular targeted co-delivery of shMDR1 and gefitinib with chitosan nanoparticles for overcoming multidrug resistance
por: Yu, Xiwei, et al.
Publicado: (2015) -
Co-delivery of Gefitinib and chloroquine by chitosan nanoparticles for overcoming the drug acquired resistance
por: Zhao, Liang, et al.
Publicado: (2015)